AllerPops: We will liberate millions from allergies | Wefunder
He went outside for a break, but more tears arose accompanied by sneezing and tightness in the chest
Click here to read the story about how we developed AllerPops
These are the results of our customer satisfaction survey that we performed in the US between 2019 and 2020. According to , the rate of satisfaction is 70% (4 stars and 5 stars). Our planned independent clinical trial will produce more accurate results. Amazon's rating
AllerPops and associated methods have been protected by three US patents, (US Pat , US , US ). We have submitted patent applications to 5 major international markets. No._9,795,579 2019/0343900 A1 10,471,033 B2
Besides the patents, we know the best protection to our IP is extraordinary customer experience with our product and service. We strive to continuously improve our product and service to fulfill the need of the expected fast market expansion in the next 5-10 years
AllerPops are sold on , , and at 5 independent pharmacies. AllerPops is so popular locally that a lady in a Los Alamos pharmacy told us last spring, "We sell AllerPops like water." Amazon allerpops.com
Our current is 28% according to Amazon sales. Many of them come back to buy for their family and friends. return customer rate
With the success in local markets, we are ready to expand into national and international markets
AllerPops is not only a revolutionary product but also a . As a customer/investor told us, " We need to bring the awareness of probiotics in the mouth, to the same awareness of probiotics in the gut." movement for the awareness of our probiotics in the mouth and airway
Our clinical trial is designed to kickstart just that. This double-blind, placebo-controlled trial, performed by an independent clinical trial company, will produce high-quality peer-reviewed publications. The trial results will announce to the entire world that AllerPops produces sustained allergy-relief and that it does that by engaging good bacteria in the mouth
Please download and read the primary research in the section below for a detailed illustration
We will promote/facilitate media coverage of this cornerstone discovery
Within 12-16 MonthsPath to Multiple Million-dollar Sales
: Independent third party will perform the clinical trial in the first half of 2021 with a feasibility study almost done. The clinical trial will produce 1. a peer-reviewed publication, 2. FDA application.AllerPops clinical trial
: The founder's influence convinced local media, TV and newspapers, to cover AllerPops. Results from a successful clinical trial will get the national media's attention. They shall cover the story for the benefit of their audience. According to our past experience, national media coverage will facilitate a projected sale of 80,000 to 100,000 boxes of AllerPops with a revenue of two million dollars. We will synchronize the trial publication with allergy seasons.Media promotion
to sustain the momentum. The TV ad is our most efficient marketing channel currently. We will choose national/local (allergy capitals) news channels to brand and market. Continuous branding and marketing
: We are satisfied with recent services from GoingClear and will continue to work with them to improve our online presence. Digital Marketing
: We will approach major franchise chain drug stores for the distribution of AllerPops. A consultant has signed a contract with us for this market expansion.Retailors
: We will use Alibaba as a platform for B2B distribution. Besides independent pharmacies, government branches can be our major B2B partners, such as VA hospitals, Armed Forces, National Park Service. B2B
: ; : 505 695 4236Question [email protected] phone
Wefunder means Wefunder Inc and its wholly owned subsidiaries: Wefunder Advisors LLC and Wefunder Portal LLC. This page is hosted by Wefunder Portal LLC
Wefunder Portal LLC is a member of the . Wefunder is risky. Don’t invest more than you can afford to lose. Financial Industry Regulatory Authority (FINRA) Investing on